Table 2 Univariable analysis in whole population: OS stratified by principal demographics and clinical characteristics
Characteristics | HR | Lower 95% CI | Upper 95% CI | p-value |
|---|---|---|---|---|
Gender | ||||
Male vs female | 1.24 | 0.86 | 1.79 | 0.259 |
Age | ||||
Continuous values | 1.08 | 1.07 | 1.10 | <0.001 |
BMI | ||||
Continuous values | 0.98 | 0.94 | 1.02 | 0.312 |
≥30 | — | |||
<30 | 0.66 | 0.40 | 1.03 | 0.113 |
Diabetes | ||||
No | — | |||
Yes | 1.54 | 1.06 | 2.22 | 0.023 |
Hypertension | ||||
No | — | |||
Yes | 1.68 | 1.15 | 2.45 | 0.008 |
Dysplidaemia | ||||
No | — | |||
Yes | 1.63 | 1.12 | 2.37 | 0.011 |
CAD | ||||
No | — | |||
Yes | 2.85 | 1.98 | 4.09 | <0.001 |
Cancer | ||||
No | — | |||
Yes | 2.79 | 1.76 | 4.42 | <0.001 |
Lymphocytes | ||||
<1000 | — | |||
≥1000 | 0.53 | 0.36 | 0.77 | 0.001 |
LDH | ||||
<248 | — | |||
≥248 | 2.85 | 1.57 | 5.18 | 0.001 |
IL-6 | ||||
No | — | |||
Yes | 0.71 | 0.36 | 1.38 | 0.306 |
PCT | ||||
<0.5 | — | |||
≥0.5 | 3.24 | 2.27 | 4.62 | <0.001 |
CRP | ||||
<0.5 | ||||
≥0.5 | 3.59 | 0.50 | 25.68 | 0.203 |
Ferritin | ||||
<336.2 | ||||
≥336.2 | 1.32 | 0.83 | 2.09 | 0.238 |
Smoking | ||||
No/former | ||||
Yes | 3.17 | 2.03 | 4.95 | <0.001 |
NLR | ||||
1.03 | 1.01 | 1.04 | <0.001 | |
PaO2/FiO2 | ||||
0.99 | 0.99 | 1.00 | <0.001 | |
Ground glass | ||||
No | ||||
Yes | 1.43 | 0.59 | 3.51 | 0.431 |
Pulmonary consolidations | ||||
No | — | |||
Yes | 1.42 | 0.99 | 2.05 | 0.60 |
Pleural effusion | ||||
No | — | |||
Yes | 1.10 | 0.75 | 1.60 | 0.625 |
Pulmonary adenopathy | ||||
No | — | |||
Yes | 1.43 | 0.59 | 3.51 | 0.431 |
